SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-24-047781
Filing Date
2024-04-16
Accepted
2024-04-16 16:10:57
Documents
6

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2411904d1_s3.htm S-3 236661
2 EXHIBIT 5.1 tm2411904d1_ex5-1.htm EX-5.1 10536
3 EXHIBIT 23.1 tm2411904d1_ex23-1.htm EX-23.1 2697
4 EX-FILING FEES tm2411904d1_ex-filingfees.htm EX-FILING FEES 16969
5 GRAPHIC tm2411904d1_ex5-1img001.jpg GRAPHIC 3102
6 GRAPHIC tm2411904d1_s3img01.jpg GRAPHIC 5753
  Complete submission text file 0001104659-24-047781.txt   280579
Mailing Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737
Business Address 600 MADISON AVENUE, SUITE 1601 NEW YORK NY 10022-1737 302 355-0650
iBio, Inc. (Filer) CIK: 0001420720 (see all company filings)

IRS No.: 262797813 | State of Incorp.: DE | Fiscal Year End: 0630
Type: S-3 | Act: 33 | File No.: 333-278729 | Film No.: 24847924
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)